The Impact of Perineural Injection Therapy for Adhesive Capsulitis.

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversiti Teknologi Mara

About this trial

The goal of this clinical trial is to learn if Perineural Injection Therapy (PIT) works to treat adhesive capsulitis (frozen shoulder) in adults. It will also learn about the safety of PIT.

The main questions it aims to answer are:

Does PIT reduce shoulder pain and improve shoulder range of motion more effectively than conventional therapy alone?

What side effects or medical problems do participants experience when receiving PIT?

Researchers will compare PIT to conventional therapy to see if PIT works better to treat adhesive capsulitis.

Participants will:

Receive either:

PIT once weekly for 6 weeks plus physiotherapy and oral analgesics (excluding NSAIDs), or

Conventional therapy only (physiotherapy and analgesics including NSAIDs)

Attend scheduled follow-up visits at Week 6, 1 month, and 3 months after treatment

Perform daily home-based shoulder exercises and record their analgesic use and any side effects in a patient diary

Eligibility criteria

Qualifiers

Age 18 and above.

Diagnosed with primary adhesive capsulitis by a specialist.

Limitation of range of motion ≥ 50% relative to the normal side or normal reference (in patient with bilateral adhesive capsulitis) in three or more movement directions (i.e., external rotation, abduction, forward flexion, and internal rotation).

Chronic adhesive capsulitis shoulder pain lasting for at least 3 months.

Disqualifiers

Received any shoulder pain injection within the past 6 weeks or surgical intervention such manipulation under anesthesia, arthroscopic capsular release, or open surgery for capsular release.

Diagnosed with other shoulder pathology such as neurologic deficits affecting shoulder function, tumour, rotator cuff injury or fracture.

Has history of allergy to dextrose solution.

Patients receiving steroidsimmunosuppressants, psychotropic medication, or other medications that may affect, the clinical outcomes

Trial design

Treatments tested in this trial

  • perineural injection
  • Physiotherapy

Treatment groups

24 Participants
are divided into 2 treatment groups

Sponsors and collaborators